FRSLX
Price
$28.09
Change
-$0.22 (-0.78%)
Updated
Oct 7 closing price
Net Assets
169.97M
FSMAX
Price
$101.54
Change
-$1.22 (-1.19%)
Updated
Oct 7 closing price
Net Assets
41.44B
Interact to see
Advertisement

FRSLX vs FSMAX

Header iconFRSLX vs FSMAX Comparison
Open Charts FRSLX vs FSMAXBanner chart's image
Nuveen Small/Mid Cap Growth Opp A
Price$28.09
Change-$0.22 (-0.78%)
VolumeN/A
Net Assets169.97M
Fidelity Extended Market Index
Price$101.54
Change-$1.22 (-1.19%)
VolumeN/A
Net Assets41.44B
FRSLX vs FSMAX Comparison Chart in %
View a ticker or compare two or three
VS
FRSLX vs. FSMAX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRSLX is a Buy and FSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.4B vs. FRSLX (170M). FSMAX pays higher dividends than FRSLX: FSMAX (0.44) vs FRSLX (0.00). FRSLX was incepted earlier than FSMAX: FRSLX (31 years) vs FSMAX (14 years). FRSLX (1.24) is less costly to investors than FSMAX (0.04). FRSLX is a more actively managed with annual turnover of: 58.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than FRSLX: FSMAX (0) vs FRSLX (3000). FSMAX annual gain was more profitable for investors over the last year : 19.58 vs. FRSLX (13.15). FSMAX return over 5 years is better than : 53.17 vs. FRSLX (-20.94).
FRSLXFSMAXFRSLX / FSMAX
Total Expense Ratio1.130.043,229%
Annual Report Gross Expense Ratio1.240.043,543%
Fund Existence31 years14 years-
Gain YTD7.52013.07258%
Front Load6%N/A-
Min. Initial Investment30000-
Min. Initial Investment IRAN/AN/A-
Net Assets170M41.4B0%
Annual Yield % from dividends0.000.44-
Returns for 1 year13.1519.5867%
Returns for 3 years52.7870.0275%
Returns for 5 years-20.9453.17-39%
Returns for 10 years-30.08107.23-28%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYHCX92.27N/A
N/A
Rydex Health Care C
SCAYX12.14N/A
N/A
Invesco Income Advantage U.S. Fund Y
LMGFX77.49N/A
N/A
ClearBridge International Growth FI
GCSLX23.88N/A
N/A
Victory Pioneer Global Equity C
CFJAX35.94N/A
N/A
Calvert US Large Cap Value Rspnb Idx A